Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiang Ling

Showing results (121-130 of 416) with videos related to

Pageof 42
Sort By:
Zhongguo Dang Dai Er Ke Za Zhi = Chinese Journal of Contemporary Pediatrics|July 27, 2022
[Recurrent epistaxis with coagulation disorders in a boy aged 2 years]Jia-Zhuo Li, Xin Tian, Chu-Shu Liao, et al.
Medical Oncology (Northwood, London, England)|July 10, 2014
Clinical significance of autophagic protein LC3 levels and its correlation with XIAP expression in hepatocellular carcinomaWen-Yong Wu, Hyunchul Kim, Chang-Le Zhang, et al.
ACS Nano|December 21, 2020
Sequential Treatment of Bioresponsive Nanoparticles Elicits Antiangiogenesis and Apoptosis and Synergizes with a CD40 Agonist for Antitumor ImmunityXiang Ling, Xiaomin Jiang, Youyou Li, et al.
Chinese Medical Journal|March 3, 2010
Dexamethasone impairs the differentiation and maturation of murine dendritic cells by Toll-like receptor 4-nuclear factor-kappaB pathwayXiao-kui He, Xiang-ling Wu, Xiu-juan He, et al.
Plos One|October 3, 2012
A novel small molecule FL118 that selectively inhibits survivin, Mcl-1, XIAP and cIAP2 in a p53-independent manner, shows superior antitumor activityXiang Ling, Shousong Cao, Qiuying Cheng, et al.
ACS Nano|November 22, 2024
Correction to "Sequential Treatment of Bioresponsive Nanoparticles Elicits Antiangiogenesis and Apoptosis and Synergizes with a CD40 Agonist for Antitumor Immunity"Xiang Ling, Xiaomin Jiang, Youyou Li, et al.
Molecular Pharmaceutics|December 17, 2013
Antitumor activity of FL118, a survivin, Mcl-1, XIAP, and cIAP2 selective inhibitor, is highly dependent on its primary structure and steric configurationJiuyang Zhao, Xiang Ling, Shousong Cao, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 1, 2022
Depleting receptor tyrosine kinases EGFR and HER2 overcomes resistance to EGFR inhibitors in colorectal cancerLu Yang, Arup Bhattacharya, Yun Li, et al.
Frontiers in Pharmacology|March 16, 2018
Significant Suppression of Non-small-cell Lung Cancer by Hydrophobic Poly(ester amide) Nanoparticles with High Docetaxel LoadingXing Chen, Lili Zhao, Yang Kang, et al.
Chemical Communications (Cambridge, England)|October 18, 2014
A highly sensitive ratiometric electrochemiluminescent biosensor for microRNA detection based on cyclic enzyme amplification and resonance energy transferNan Hao, Xiang-Ling Li, Huai-Rong Zhang, et al.
Pageof 42

Showing results (121-130 of 416) with videos related to

Sort By:
Pageof 42
Zhongguo Dang Dai Er Ke Za Zhi = Chinese Journal of Contemporary Pediatrics|July 27, 2022
[Recurrent epistaxis with coagulation disorders in a boy aged 2 years]Jia-Zhuo Li, Xin Tian, Chu-Shu Liao, et al.
Medical Oncology (Northwood, London, England)|July 10, 2014
Clinical significance of autophagic protein LC3 levels and its correlation with XIAP expression in hepatocellular carcinomaWen-Yong Wu, Hyunchul Kim, Chang-Le Zhang, et al.
ACS Nano|December 21, 2020
Sequential Treatment of Bioresponsive Nanoparticles Elicits Antiangiogenesis and Apoptosis and Synergizes with a CD40 Agonist for Antitumor ImmunityXiang Ling, Xiaomin Jiang, Youyou Li, et al.
Chinese Medical Journal|March 3, 2010
Dexamethasone impairs the differentiation and maturation of murine dendritic cells by Toll-like receptor 4-nuclear factor-kappaB pathwayXiao-kui He, Xiang-ling Wu, Xiu-juan He, et al.
Plos One|October 3, 2012
A novel small molecule FL118 that selectively inhibits survivin, Mcl-1, XIAP and cIAP2 in a p53-independent manner, shows superior antitumor activityXiang Ling, Shousong Cao, Qiuying Cheng, et al.
ACS Nano|November 22, 2024
Correction to "Sequential Treatment of Bioresponsive Nanoparticles Elicits Antiangiogenesis and Apoptosis and Synergizes with a CD40 Agonist for Antitumor Immunity"Xiang Ling, Xiaomin Jiang, Youyou Li, et al.
Molecular Pharmaceutics|December 17, 2013
Antitumor activity of FL118, a survivin, Mcl-1, XIAP, and cIAP2 selective inhibitor, is highly dependent on its primary structure and steric configurationJiuyang Zhao, Xiang Ling, Shousong Cao, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 1, 2022
Depleting receptor tyrosine kinases EGFR and HER2 overcomes resistance to EGFR inhibitors in colorectal cancerLu Yang, Arup Bhattacharya, Yun Li, et al.
Frontiers in Pharmacology|March 16, 2018
Significant Suppression of Non-small-cell Lung Cancer by Hydrophobic Poly(ester amide) Nanoparticles with High Docetaxel LoadingXing Chen, Lili Zhao, Yang Kang, et al.
Chemical Communications (Cambridge, England)|October 18, 2014
A highly sensitive ratiometric electrochemiluminescent biosensor for microRNA detection based on cyclic enzyme amplification and resonance energy transferNan Hao, Xiang-Ling Li, Huai-Rong Zhang, et al.
Pageof 42